Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Catalano

Showing results (331-340 of 341) with videos related to

Pageof 35
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2019
irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical TrialJean-Christophe Pignon, Opeyemi Jegede, Sachet A Shukla, et al.
Obesity (Silver Spring, Md.)|October 15, 2013
Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dogMarilyn Ader, Darko Stefanovski, Stella P Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2020
Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell CarcinomaMiriam Ficial, Opeyemi A Jegede, Miriam Sant'Angelo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2023
PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma PatientsThomas Denize, Opeyemi A Jegede, Sayed Matar, et al.
JAMA Network Open|August 10, 2023
Development and Validation of an Automated Image-Based Deep Learning Platform for Sarcopenia Assessment in Head and Neck CancerZezhong Ye, Anurag Saraf, Yashwanth Ravipati, et al.
JAMA|February 19, 2026
Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation: A Randomized Clinical TrialAyal A Aizer, Kee-Young Shin, Paul J Catalano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2025
Stereotactic Radiosurgery in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases: A Multi-Institutional, Phase II, Prospective Clinical TrialAyal A Aizer, Shyam K Tanguturi, Diana D Shi, et al.
Nature Communications|November 9, 2023
Automated temporalis muscle quantification and growth charts for children through adulthoodAnna Zapaishchykova, Kevin X Liu, Anurag Saraf, et al.
Cancers|February 13, 2026
Characterization of Clinical Outcomes for Patients with Relapsed High-Risk Neuroblastoma After Autologous Stem Cell Transplant and External Beam RadiotherapyMathew Lin, Jie Jane Chen, Rochelle Bagatell, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 16, 2024
Patterns of recurrence after radiotherapy for high-risk neuroblastoma: Implications for radiation dose and fieldKevin X Liu, Sherif G Shaaban, Jie Jane Chen, et al.
Pageof 35

Showing results (331-340 of 341) with videos related to

Sort By:
Pageof 35
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2019
irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical TrialJean-Christophe Pignon, Opeyemi Jegede, Sachet A Shukla, et al.
Obesity (Silver Spring, Md.)|October 15, 2013
Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dogMarilyn Ader, Darko Stefanovski, Stella P Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2020
Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell CarcinomaMiriam Ficial, Opeyemi A Jegede, Miriam Sant'Angelo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2023
PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma PatientsThomas Denize, Opeyemi A Jegede, Sayed Matar, et al.
JAMA Network Open|August 10, 2023
Development and Validation of an Automated Image-Based Deep Learning Platform for Sarcopenia Assessment in Head and Neck CancerZezhong Ye, Anurag Saraf, Yashwanth Ravipati, et al.
JAMA|February 19, 2026
Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation: A Randomized Clinical TrialAyal A Aizer, Kee-Young Shin, Paul J Catalano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2025
Stereotactic Radiosurgery in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases: A Multi-Institutional, Phase II, Prospective Clinical TrialAyal A Aizer, Shyam K Tanguturi, Diana D Shi, et al.
Nature Communications|November 9, 2023
Automated temporalis muscle quantification and growth charts for children through adulthoodAnna Zapaishchykova, Kevin X Liu, Anurag Saraf, et al.
Cancers|February 13, 2026
Characterization of Clinical Outcomes for Patients with Relapsed High-Risk Neuroblastoma After Autologous Stem Cell Transplant and External Beam RadiotherapyMathew Lin, Jie Jane Chen, Rochelle Bagatell, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 16, 2024
Patterns of recurrence after radiotherapy for high-risk neuroblastoma: Implications for radiation dose and fieldKevin X Liu, Sherif G Shaaban, Jie Jane Chen, et al.
Pageof 35